Interestingly, downregulation of TRX inhibitory protein VDUP1, and upregulation of PRDX3 and PRDX4, correlated with poor prognosis of DLBCL patients, indicating tumor-promoting role of TRX-like enzymes in lymphomas [31]. Here, TXNIP is linked to lymphoma.